Stocks and Investing Stocks and Investing
Tue, March 5, 2024

David Amsellem Maintained (AVDL) at Buy with Increased Target to $23 on, Mar 5th, 2024


Published on 2024-10-28 09:27:29 - WOPRAI, David Amsellem
  Print publication without navigation


David Amsellem of Piper Sandler, Maintained "Avadel Pharmaceuticals plc" (AVDL) at Buy with Increased Target from $18 to $23 on, Mar 5th, 2024.

David has made no other calls on AVDL in the last 4 months.



There is 1 other peer that has a rating on AVDL. Out of the 1 peers that are also analyzing AVDL, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David


  • Ashwani Verma of "UBS" Initiated at Strong Buy and Held Target at $21 on, Tuesday, February 6th, 2024
Contributing Sources